News & Updates

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

For patients undergoing laparoscopic resection for colorectal cancer (CRC), two sessions of transcranial direct current stimulation (tDCS) help reduce perioperative anxiety, as reported in a study.

The use of nasal spray zavegepant 10 mg provides freedom from pain and the most bothersome migraine symptom (MBS*) at 2 hours after treatment in women with acute migraine, according to the pooled analysis of the two trials presented at AAN 2024.

Using intravascular ultrasound (IVUS) to guide stent placement in patients with acute coronary syndrome (ACS) appears to reduce the 1-year risk of target vessel failure as compared with using angiography alone, according to the results of the IVUS-ACS study.

A pharmacist monitoring program is feasible and useful for patients receiving oral antineoplastic agents, reports a recent study.

Chocolate lovers may want to think twice before indulging in this confection as a recent study reports an association between nontyphoidal salmonellosis transmission and chocolate consumption.

A program that teaches self-administered acupressure (SAA), coupled with a brief knee health education, works well in terms of alleviating knee pain and improving mobility in middle-aged and older adults with probable knee osteoarthritis (OA), according to a study from Hong Kong.

Among patients with atherosclerotic cardiovascular disease (ASCVD) who fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals despite receiving maximally tolerated statins, initiating inclisiran immediately resulted in significant reductions in LDL-C, according to the VICTORION-INITIATE trial presented at ACC.24.